10.31
-0.34 (-3.19%)
前收盘价格 | 10.65 |
收盘价格 | 10.61 |
成交量 | 2,853,420 |
平均成交量 (3个月) | 2,439,559 |
市值 | 1,279,172,096 |
市盈率 (P/E TTM) | 51.55 |
预期市盈率 (P/E Forward) | 28.25 |
价格/销量 (P/S) | 4.43 |
股市价格/股市净资产 (P/B) | 2.24 |
52周波幅 | |
利润日期 | 6 May 2025 - 12 May 2025 |
营业毛利率 | -20.39% |
营业利益率 (TTM) | -31.40% |
稀释每股收益 (EPS TTM) | -0.500 |
季度收入增长率 (YOY) | 34.20% |
季度盈利增长率 (YOY) | 3,119.20% |
总债务/股东权益 (D/E MRQ) | 54.64% |
流动比率 (MRQ) | 11.93 |
营业现金流 (OCF TTM) | 63.55 M |
杠杆自由现金流 (LFCF TTM) | 33.54 M |
资产报酬率 (ROA TTM) | -0.07% |
股东权益报酬率 (ROE TTM) | -10.45% |
市场趋势
短期 | 中期 | ||
行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
股票 | Dynavax Technologies Corporatio | 看跌 | 看跌 |
AIStockmoo 评分
分析师共识 | 1.5 |
内部交易活动 | NA |
价格波动 | 4.5 |
技术平均移动指标 | -2.5 |
技术振荡指标 | -2.0 |
平均 | 0.38 |
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B. |
|
部门 | Healthcare |
行业 | Drug Manufacturers - Specialty & Generic |
投资方式 | Small Core |
内部持股比例 | 0.55% |
机构持股比例 | 108.77% |
52周波幅 | ||
目标价格波幅 | ||
高 | 31.00 (JMP Securities, 200.68%) | 购买 |
中 | 20.50 (98.84%) | |
低 | 10.00 (Goldman Sachs, -3.01%) | 卖出 |
平均值 | 20.50 (98.84%) | |
总计 | 1 购买, 1 卖出 | |
平均价格@调整类型 | 10.02 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
JMP Securities | 07 May 2025 | 31.00 (200.68%) | 购买 | 9.72 |
Goldman Sachs | 17 Apr 2025 | 10.00 (-3.01%) | 卖出 | 10.31 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合